Anjuli Mehrotra is a Rheumatology/Immunology physician affiliated with Stanford University. OpenAlex indexes 13 publications with 549 citations (h-index 5).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
725 Welch Rd
Palo Alto, CA 943041601
Telephone
650-497-8000Provider last certified this registry record 15 Apr 2024.
Industry payments
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- AQUESTIVE THERAPEUTICS, INC.Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2020)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Respiratory
100%Leukotriene Receptor Antagonist100%Montelukast Sodium100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Erratum to: Safety and feasibility of oral immunotherapy to multiple allergens for food allergy
Allergy Asthma and Clinical Immunology
2016 - Phase 1 results of safety and tolerability in a rush oral immunotherapy protocol to multiple foods using Omalizumab
Allergy Asthma and Clinical Immunology
2014 - Safety and feasibility of oral immunotherapy to multiple allergens for food allergy
Allergy Asthma and Clinical Immunology
2014 - Multiple-allergen oral immunotherapy improves quality of life in caregivers of food-allergic pediatric subjects
Allergy Asthma and Clinical Immunology
2014 - The safety of multiple oral immunotherapy in phase one studies at a single center
Clinical and Translational Allergy
2013
Similar KOLs
Other experts from the same institution or the same specialty.
Renumathy Dhanasekaran, MD, PhD
Stanford University
Euan Ashley, MD
Stanford University
Sarah Donaldson, MD
Stanford University
Peter Fitzgerald, MD
Stanford University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”